a
a
Weather:
No weather information available
HomeHealthSIFI receives Marketing Authorisation and Promising Innovative Medicine Designation for AKANTIOR® in the UK

SIFI receives Marketing Authorisation and Promising Innovative Medicine Designation for AKANTIOR® in the UK

MHRA granted on 6th May the Promising Innovative Medicine (PIM) Designation MHRA granted on 15th May the Marketing Authorisation, confirming the Orphan Drug Designation and the New Active Substance status CATANIA, Italy, May 19, 2025 /PRNewswire/ — SIFI, a leading international…

No comments

Sorry, the comment form is closed at this time.

Translate »